Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05391828 · ClinicalTrials.gov registry record · NA

Persona MC vs PS RCT With ROSA

A NA study of Total Knee Arthroplasty, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05391828 is a NA study of Total Knee Arthroplasty that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 288-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05391828, a NA study of Total Knee Arthroplasty, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

A randomized, controlled study comparing two total knee implant devices, Persona medial congruent (MC) vs posterior stabilized (PS). These surgeries will be performed using the ROSA robotic system. Patients will be followed up to 5 years.

Conditions Studied

Interventions

  • DEVICE Zimmer-Biomet Persona Medial Congruent (MC) Bearing Design
  • DEVICE Zimmer-Biomet Persona Posterior-Stabilized (PS) Bearing Design

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-09-27
Est. Completion 2026-12
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05391828

The ClinicalTrials.gov registry entry for NCT05391828 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (31% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Zimmer-Biomet Persona Medial Congruent (MC) Bearing Design is the first listed.

NCT05391828 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05391828 about?

NCT05391828 is a clinical study titled "Persona MC vs PS RCT With ROSA". A randomized, controlled study comparing two total knee implant devices, Persona medial congruent (MC) vs posterior stabilized (PS). These surgeries will be performed using the ROSA robotic system. Patients will be followed up to 5 years.

What is the current status of trial NCT05391828?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-09-27. Estimated completion is 2026-12.

What conditions does trial NCT05391828 study?

This clinical trial studies the following conditions: Total Knee Arthroplasty.

What interventions are being tested in trial NCT05391828?

The interventions under investigation include: Zimmer-Biomet Persona Medial Congruent (MC) Bearing Design (DEVICE), Zimmer-Biomet Persona Posterior-Stabilized (PS) Bearing Design (DEVICE).

Who is sponsoring clinical trial NCT05391828?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05391828 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Knee Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.